|
ERLIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.38530339713839E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49830037265986E-10 |
| Normal-vs-Stage2 |
2.355200E-03 |
| Normal-vs-Stage3 |
1.95182999999099E-05 |
| Normal-vs-Stage4 |
4.804400000058E-07 |
| Stage1-vs-Stage2 |
4.725800E-01 |
| Stage1-vs-Stage3 |
7.076400E-01 |
| Stage1-vs-Stage4 |
3.023600E-01 |
| Stage2-vs-Stage3 |
7.208400E-01 |
| Stage2-vs-Stage4 |
1.671410E-01 |
| Stage3-vs-Stage4 |
1.872610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.20949966392936E-11 |
| Normal-vs-AfricanAmerican |
9.29220000944753E-09 |
| Normal-vs-Asian |
2.31840000000094E-05 |
| Caucasian-vs-AfricanAmerican |
9.778800E-01 |
| Caucasian-vs-Asian |
2.822200E-01 |
| AfricanAmerican-vs-Asian |
2.950800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.06166244871065E-12 |
| Normal-vs-Female |
3.13640000004778E-06 |
| Male-vs-Female |
4.371500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.35270000148446E-08 |
| Normal-vs-Extreme_Weight |
2.66864308429149E-12 |
| Normal-vs-Obese |
4.00569999947642E-07 |
| Normal-vs-Extreme_Obese |
2.582300E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.594000E-01 |
| Normal_Weight-vs-Obese |
2.654000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.679000E-01 |
| Extreme_Weight-vs-Obese |
4.798100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.186200E-01 |
| Obese-vs-Extreme_Obese |
8.135800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.447550E-02 |
| Normal-vs-Age(41-60Yrs) |
1.18380000246887E-08 |
| Normal-vs-Age(61-80Yrs) |
3.54316576078872E-12 |
| Normal-vs-Age(81-100Yrs) |
1.01839999999687E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.357400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.458200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.905880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.685800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65619740144507E-11 |
| Normal-VS-Type2 PRCC |
4.03409999849558E-08 |
| Normal-VS-KIRP CIMP |
2.906300E-02 |
| Normal-VS-Unclassified PRCC |
1.360450E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.513400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.847800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.383770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.542800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.652200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.325800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.59879995090762E-09 |
| Normal-vs-N1 |
4.58449999962696E-07 |
| Normal-vs-N2 |
4.980600E-01 |
| N0-vs-N1 |
9.757600E-01 |
| N0-vs-N2 |
1.738050E-01 |
| N1-vs-N2 |
2.146200E-01 |
|
|
